Skip to main content

Search articles in News

Found 2,566 articles

  • Qnovia, Inc. Announces the Appointment of Four New

    Qnovia, Inc. Announces the Appointment of Four New Members to its Scientific Advisory Board

    • 10 Apr 2024
    • Editor

    Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRxTM, today announced the appointment of four new members to its Scientific Advisory Board (SAB).

  • Bayer and Google Cloud Collaborate to Bring Respon

    Bayer and Google Cloud Collaborate to Bring Responsible AI Solutions to Radiologists

    • 9 Apr 2024
    • Editor

    Bayer and Google Cloud today announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients.

  • Thermo Fisher Scientific Launches New ENERGY STAR

    Thermo Fisher Scientific Launches New ENERGY STAR certified TSX Universal Series ULT Freezers to Deliver Tighter Temperature Control and Faster Recovery Times

    • 9 Apr 2024
    • Editor

    Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific today introduces its newest line of high performance, ultra-low temperature (ULT) freezers.

  • Labcorp Announces Expansion of Precision Oncology

    Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs

    • 9 Apr 2024
    • Editor

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the strategic expansion of its precision oncology portfolio, solidifying its commitment to advancing cancer research and patient care on a global scale.

  • Top Ten Companies Hiring in April 2024

    Top Ten Companies Hiring in April 2024

    • 8 Apr 2024
    • Nola Cadman

    Here's a list of the top pharma and life science companies hiring in April on PharmiWeb.jobs

  • Top Ten Recruiters Hiring in April 2024

    Top Ten Recruiters Hiring in April 2024

    • 8 Apr 2024

    Here are the top Pharma and Life Science recruitment organisations advertising in April 2024 on PharmiWeb.jobs

  • 9 Clinical Data Management Career Paths

    9 Clinical Data Management Career Paths

    • 8 Apr 2024
    • Lucy Walters

    As the life science industry becomes increasingly data-driven, the field of clinical data management (CDM) is expanding, offering a wealth of career opportunities for those interested in leveraging data to improve patient outcomes and healthcare processes.

  • Results announced from EMPACT-MI phase III trial i

    Results announced from EMPACT-MI phase III trial investigating the effect of Jardiance® (empagliflozin) on risk of heart failure hospitalization and death in adults following a heart attack

    • 8 Apr 2024
    • Editor

    The EMPACT-MI phase III clinical trial showed a 10% relative risk reduction in the primary composite endpoint of time to first hospitalization due to heart failure or all-cause mortality for empagliflozin versus placebo, which did not reach statistical significance.

  • Enhertu approved in the US as first tumour-agnosti

    Enhertu approved in the US as first tumour-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumours

    • 8 Apr 2024
    • Editor

    AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic HER2-positive (IHC 3+) solid tumours who have received prior systemic treatment and have no satisfactory alternative treatment options.

  • A Recruiter’s Guide to Hiring a Clinical Data Mana

    A Recruiter’s Guide to Hiring a Clinical Data Manager

    • 5 Apr 2024
    • Lucy Walters

    From understanding the unique demands of the role to identifying key competencies and conducting effective interviews, this guide will provide you with valuable tips to help you focus your candidate search and engage top talent.

  • Parexel Named “Best Contract Research Organization

    Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards

    • 5 Apr 2024
    • Editor

    Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been named “Best Contract Research Organization” at the 17th Annual Vaccine Industry Excellence (ViE) Awards.

  • Artificial Intelligence and Machine Learning in Cl

    Artificial Intelligence and Machine Learning in Clinical Data Management: Opportunities and Ethical Considerations

    • 4 Apr 2024
    • Lucy Walters

    Artificial Intelligence (AI) and Machine Learning (ML) promise to revolutionise how clinical data is collected, analysed, and utilised, offering unprecedented opportunities for enhancing trial efficiency and patient outcomes.

  • Phase 1/2 Interim Data on Moderna’s mRNA-3927, an

    Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature

    • 4 Apr 2024
    • Editor

    Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human, phase 1/2, open-label, dose optimization study and extension study, evaluating the safety and efficacy of mRNA-3927, an investigational mRNA therapy for propionic acidemia (PA), has been published in Nature.

  • REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug D

    REJOICE-Ovarian01 Phase 2/3 Trial of Raludotatug Deruxtecan Initiated in Patients With Platinum-Resistant Ovarian Cancer

    • 4 Apr 2024
    • Editor

    Daiichi Sankyo (TSE: 4568) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the first patient has been dosed in the REJOICE-Ovarian01 Phase 2/3 trial evaluating the efficacy and safety of investigational raludotatug deruxtecan (R-DXd) in patients with platinum-resistant ovarian cancer.

  • Opthea Appoints Sujal Shah to the Board of Directo

    Opthea Appoints Sujal Shah to the Board of Directors

    • 4 Apr 2024
    • Editor

    Opthea Limited (ASX/NASDAQ: OPT “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced the appointment of Sujal Shah to the Company’s Board of Directors (the “Board”), effective April 4, 2024.

  • ICON Announces CFO Transition

    ICON Announces CFO Transition

    • 4 Apr 2024
    • Editor

    ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that Chief Financial Officer, Brendan Brennan, will leave his role at ICON in quarter four this year for a new opportunity outside of the CRO industry.

  • Europe’s generic medicines are disappearing – acco

    Europe’s generic medicines are disappearing – according to new research – drastic action required to prevent crisis

    • 3 Apr 2024
    • Editor

    Research from Teva Pharmaceuticals shows that Europe’s critical medicine cabinets – in hospitals, pharmacies, and homes – are home to fewer generic medicines. These are the often-cheaper alternatives to brand name medicines, that make up 67%[1] of all medicines.

  • What Does a Clinical Research Coordinator (CRC) Do

    What Does a Clinical Research Coordinator (CRC) Do?

    • 3 Apr 2024
    • Lucy Walters

    A Clinical Research Coordinator (CRC) is a specialised research professional who works under the direction of a Clinical Principal Investigator (PI). They play an important role in conducting and managing clinical trials, providing outcomes that shape medical advances in areas such as preventative care, cures for diseases, and immunisations.

  • Abbott Receives FDA Approval for TriClip™, First-o

    Abbott Receives FDA Approval for TriClip™, First-of-its-Kind Device to Repair Leaky Tricuspid Heart Valve

    • 3 Apr 2024
    • Editor

    Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's first-of-its-kind TriClip™ transcatheter edge-to-edge repair (TEER) system that's specifically designed for the treatment of tricuspid regurgitation (TR), or a leaky tricuspid valve.

  • FDA Expands Indication for Gilead's Vemlidy (Tenof

    FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

    • 2 Apr 2024
    • Editor

    Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B virus (HBV) infection in pediatric patients six years of age and older and weighing at least 25 kg with compensated liver disease.